Product NDC: | 0378-3205 |
Proprietary Name: | Prazosin Hydrochloride |
Non Proprietary Name: | prazosin hydrochloride |
Active Ingredient(s): | 5 mg/1 & nbsp; prazosin hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0378-3205 |
Labeler Name: | Mylan Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA072575 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130517 |
Package NDC: | 0378-3205-25 |
Package Description: | 250 CAPSULE in 1 BOTTLE, PLASTIC (0378-3205-25) |
NDC Code | 0378-3205-25 |
Proprietary Name | Prazosin Hydrochloride |
Package Description | 250 CAPSULE in 1 BOTTLE, PLASTIC (0378-3205-25) |
Product NDC | 0378-3205 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | prazosin hydrochloride |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20130517 |
Marketing Category Name | ANDA |
Labeler Name | Mylan Pharmaceuticals Inc. |
Substance Name | PRAZOSIN HYDROCHLORIDE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |